Patent: 10,226,550
✉ Email this page to a colleague
Summary for Patent: 10,226,550
Title: | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
Abstract: | This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application. |
Inventor(s): | Savage; Paul B. (Mapleton, UT), Genberg; Carl (Las Vegas, NV), Bracken; Ronald (Monroe, GA) |
Assignee: | BRIGHAM YOUNG UNIVERSITY (Provo, UT) |
Application Number: | 15/454,135 |
Patent Claims: | see list of patent claims |
Details for Patent 10,226,550
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Subscribe | 2036-03-11 |
Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Subscribe | 2036-03-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |